Vaginal DNA Assay Shows Promise - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

  • By

  • Kerri Miller

  • May 8, 2026

  • 14 min

Share

Original Source(s)

Vaginal DNA Assay Shows Promise

  • by Kerri Miller

  • May 8, 2026

Related Content

Cancer Screening Gaps Seen in Sexual, Gender Minority Groups

A large BRFSS analysis points to persistent screening disparities among sexual orientation and gender identity minority respondents, with particularly large gaps in some gender identity minority groups.

Editorial: Transitioning through menopause: contraceptive choices and sexual well-being

Population-Level Outcomes for Screening Program Cancers in First Nations People in Ontario, Canada